These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37377898)

  • 21. CXCL10 and CCL21 Promote Migration of Pancreatic Cancer Cells Toward Sensory Neurons and Neural Remodeling in Tumors in Mice, Associated With Pain in Patients.
    Hirth M; Gandla J; Höper C; Gaida MM; Agarwal N; Simonetti M; Demir A; Xie Y; Weiss C; Michalski CW; Hackert T; Ebert MP; Kuner R
    Gastroenterology; 2020 Aug; 159(2):665-681.e13. PubMed ID: 32330476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.
    Baratelli F; Takedatsu H; Hazra S; Peebles K; Luo J; Kurimoto PS; Zeng G; Batra RK; Sharma S; Dubinett SM; Lee JM
    J Transl Med; 2008 Jul; 6():38. PubMed ID: 18644162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
    Roncati L
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokine C-C motif ligand 21 synergized with programmed death-ligand 1 blockade restrains tumor growth.
    Chen Q; Yin H; Pu N; Zhang J; Zhao G; Lou W; Wu W
    Cancer Sci; 2021 Nov; 112(11):4457-4469. PubMed ID: 34402138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.
    Avram G; Sánchez-Sendra B; Martín JM; Terrádez L; Ramos D; Monteagudo C
    Histopathology; 2013 Dec; 63(6):852-61. PubMed ID: 24102908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas.
    Zhao DX; Li ZJ; Zhang Y; Zhang XN; Zhao KC; Li YG; Zhang MM; Yu XW; Liu MY; Li Y
    Cell Immunol; 2014; 289(1-2):155-61. PubMed ID: 24838092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
    Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
    Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients.
    Rossi E; Cellini F; Pagliara MM; Sammarco MG; Pedone RR; Lancellotta V; Tagliaferri L; Quirino M; Gambacorta MA; Blasi MA; Tortora G; Schinzari G
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence.
    Cybulska-Stopa B; Rogala P; Czarnecka AM; Ługowska I; Teterycz P; Galus Ł; Rajczykowski M; Dawidowska A; Piejko K; Suwiński R; Mackiewicz J; Rutkowski P
    Adv Med Sci; 2020 Sep; 65(2):316-323. PubMed ID: 32554313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes.
    Caidahl K; Hartford M; Ravn-Fischer A; Lorentzen E; Yndestad A; Karlsson T; Aukrust P; Ueland T
    J Am Coll Cardiol; 2019 Aug; 74(6):774-782. PubMed ID: 31395128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastoma.
    Poelaert BJ; Romanova S; Knoche SM; Olson MT; Sliker BH; Smits K; Dickey BL; Moffitt-Holida AEJ; Goetz BT; Khan N; Smith L; Band H; Mohs AM; Coulter DW; Bronich TK; Solheim JC
    J Control Release; 2020 Nov; 327():266-283. PubMed ID: 32711026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.
    Fevang B; Yndestad A; Damås JK; Halvorsen B; Holm AM; Beiske K; Aukrust P; Frøland SS
    Clin Exp Immunol; 2009 Nov; 158(2):237-45. PubMed ID: 19747210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
    Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
    J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
    Padonou F; Vanhulst T; Langouo-Fontsa MD
    Curr Opin Oncol; 2024 Mar; 36(2):63-68. PubMed ID: 38441065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas.
    Mumtaz M; Wågsäter D; Löfgren S; Hugander A; Zar N; Dimberg J
    Oncol Rep; 2009 Jan; 21(1):153-8. PubMed ID: 19082456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study.
    Schinzari G; Rossi E; Cassano A; Dadduzio V; Quirino M; Pagliara M; Blasi MA; Barone C
    Melanoma Res; 2017 Dec; 27(6):591-595. PubMed ID: 29076951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma.
    Sah VR; Karlsson J; Jespersen H; Lindberg MF; Nilsson LM; Ny L; Nilsson JA
    Melanoma Res; 2022 Aug; 32(4):241-248. PubMed ID: 34753889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19.
    Tveita A; Murphy SL; Holter JC; Kildal AB; Michelsen AE; Lerum TV; Kaarbø M; Heggelund L; Holten AR; Finbråten AK; Müller KE; Mathiessen A; Bøe S; Fevang B; Granerud BK; Tonby K; Lind A; Dudman SG; Henriksen KN; Müller F; Skjønsberg OH; Trøseid M; Barratt-Due A; Dyrhol-Riise AM; Aukrust P; Halvorsen B; Dahl TB; Ueland T;
    J Infect Dis; 2022 Dec; 226(12):2150-2160. PubMed ID: 35876699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pembrolizumab as first-line treatment for metastatic uveal melanoma.
    Rossi E; Pagliara MM; Orteschi D; Dosa T; Sammarco MG; Caputo CG; Petrone G; Rindi G; Zollino M; Blasi MA; Cassano A; Bria E; Tortora G; Schinzari G
    Cancer Immunol Immunother; 2019 Jul; 68(7):1179-1185. PubMed ID: 31175402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort.
    Katra P; Hennings V; Nilsson J; Engström G; Engelbertsen D; Bengtsson E; Björkbacka H
    Atherosclerosis; 2023 Feb; 366():1-7. PubMed ID: 36652748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.